Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Progenics Restructures To Become Leaner, Focus On Oncology

This article was originally published in The Pink Sheet Daily

Executive Summary

With an eye on efficiency, the biotech plans to shed its virology and infectious disease assets and transition to a pure-play oncology company.
Advertisement

Related Content

Baker Plans Business Development Focus For Progenics Pharma
Progenics Finds New Partner For Relistor In Salix
Progenics Finds New Partner For Relistor In Salix

Topics

Advertisement
UsernamePublicRestriction

Register

PS072773

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel